View All Key Stats
ILMN Key Stats
| Income Statement | |
| Revenue (TTM) | 2.935B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.86 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 567.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.80% |
| Profit Margin (Quarterly) | 26.60% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 42.01B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.39 |
| PE Ratio (TTM) | 74.04 |
| Price to Book Value | 13.97 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 165.00M |
| Return on Equity (TTM) | Upgrade |
View All ILMN News
ILMN News
-
WireHeadlineTime (ET)
-
Globe Newswire06/12 09:10
-
Yahoo06/11 10:52
-
Yahoo06/08 09:03
-
Yahoo06/08 08:04
-
Yahoo06/07 10:32
-
Yahoo06/07 09:17
-
Yahoo06/05 17:38
-
Yahoo06/05 11:10
-
Yahoo06/05 10:48
-
Yahoo06/05 06:08
View All Events
ILMN Events
| Date | Type | Description |
|---|---|---|
| 08/01/2018 | Misc | Illumina Inc Second Quarter Earnings Conference Call in 2018 |
| 08/01/2018 | Earnings | Illumina Inc Second Quarter Earnings Results in 2018 |
| 05/23/2018 | Misc | Illumina Inc Annual General Meeting in 2017 |
| 05/15/2018 | Misc | Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis |
| 04/24/2018 17:00 EDT | Misc | Illumina Inc First Quarter Earnings Conference Call in 2018 |
| 04/24/2018 | Earnings | Illumina Inc First Quarter Earnings Results in 2018 |
| 02/13/2018 | Misc | Illumina Inc Annual Report in 2017 |
| 01/30/2018 17:00 EST | Misc | Illumina Inc Fourth Quarter Earnings Conference Call in 2017 |
| 01/30/2018 | Earnings | Illumina Inc Fourth Quarter Earnings Results in 2017 |
| 10/24/2017 17:00 EDT | Misc | Illumina Inc Third Quarter Earnings Conference Call in 2017 |
ILMN Fundamentals
Income Statement View Statement
ILMN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ILMN One Page Reports
- One Page Report Download
ILMN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 285.78 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.illumina.com
- Investor Relations URL: http://www.illumina.com/company/investor-information.html
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Large Cap/Growth
- Next Earnings Release: Aug. 01, 2018
- Last Earnings Release: Apr. 24, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
ILMN Excel Add-In Codes
- Name: =YCI("ILMN","name")
- Description: =YCI("ILMN","description")
- Sector: =YCI("ILMN","sector")
- Industry: =YCI("ILMN","industry")
- Est. Current Fiscal Year End: =YCI("ILMN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ILMN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ILMN Tweets Stocktwits
Advertisement
